FEB 21, 2018 7:30 AM PST

Keynote Presentation: Evolving Paradigms of Pharmaco-MPE (Molecular Pathological Epidemiology) and Immuno-MPE for Precision Medicine

Presented at: Drug Discovery 2018
Speaker
  • Chief, Program in MPE Molecular Pathological Epidemiology, Brigham and Women's Hospital, Professor of Pathology and Epidemiology, Harvard Medical School, Dana-Farber Cancer Institute
    Biography
      Dr. Shuji Ogino is Professor (of Pathology and Epidemiology) at Dana-Farber Cancer Institute, Brigham and Women's Hospital (BWH), Harvard Medical School, and Harvard T.H. Chan School of Public Health; the founding Chief of Program in MPE Molecular Pathological Epidemiology at BWH; and an Associate Member of Broad Institute of MIT and Harvard. Dr. Ogino has been developing the transdisciplinary science "Molecular Pathological Epidemiology (MPE)", which bridges and integrates molecular biologic and population health sciences. Since 2013, he has been the Chairperson for The International MPE Meeting Series, and the Fourth International MPE Meeting will be held in Boston in 2018 (www.mpemeeting.org). Dr. Ogino has received numerous awards and honors, including CAP Foundation Scholars Award; USCAP Ramzi Cotran Young Investigator Award; Executive Officer's Award and Meritorious Service Award from AMP; recognitions of "Most Influential Scientific Minds" in 2014, and "Highly Cited Researcher" in 2015, 2016, and 2017 by Thomson Reuters and Clarivate Analytics; elected membership in ASCI; membership of FASEB Excellence in Science Award Committee; and membership of various NIH study sections, most notably NCI R35 Outstanding Investigator Award (OIA) Special Emphasis Panel in 2016. Dr. Ogino has been a recipient of prestigious NCI R35 OIA grant, which represent 7-year funding for me to pursue paradigm-shifting high impact research.

    Abstract

    This lecture introduces the evolving paradigm of Molecular Pathological Epidemiology (MPE) as simply as possible.  Any given human disease represents fundamentally heterogeneous process, as implicated by the "unique disease principle".  MPE dissects complex interplay between environment, lifestyle factors, molecular pathogenic alterations, and disease occurrence and progression, using large populations.  MPE is a logical next step of genome-wide association studies (GWAS), termed “GWAS-MPE Approach”.  MPE has proven itself to be a promising approach to identify biomarkers for precision medicine (Chan A et al. NEJM 2007; Liao X et al. NEJM 2012; Nishihara R et al. NEJM 2013, etc.).  Recently, the "pharmaco-MPE" paradigm (Ogino S et al. npj Prec Oncol 2017) has been utilized to uncover effects of medications on health and diseases.  In addition, the "immuno-MPE" approach integrates immunology and MPE, to decipher effects of environment on immune status in health and diseases.  It is increasingly critical to design large-scale population-based MPE databases worldwide by means of integrating medication use, lifestyle factors, molecular pathology, immune status, and clinical outcome.  Such databases can generate novel information on potential chemopreventive or therapeutic benefits of drugs, which can be further tested by experimental models and clinical trials.  To expand opportunities and address challenges, the "International Molecular Pathological Epidemiology (MPE) Meeting Series" was established in 2013, and the Fourth International MPE Meeting will be held in Boston in 2018 (May 31 to June 1).  Because disease heterogeneity is a ubiquitous phenomenon, the MPE concept should be widespread to advance biomedical and population health sciences in the 21st century, and move us towards precision prevention and treatment. 


    Show Resources
    You May Also Like
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    NOV 18, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 18, 2020 8:00 AM PST
    DATE: November 18, 2020 TIME: 08:00am PDT We develop and implement technologies to solve some of the major bottlenecks in biomedical research. In particular, we establish new imaging approac...
    OCT 29, 2020 6:00 AM PDT
    C.E. CREDITS
    OCT 29, 2020 6:00 AM PDT
    Date: October 29, 2020 Time: 6:00am (PDT), 9:00am (EDT), Chronic inflammation can occur as a result of a combination of genetic predispositions and environmental factors. Epigenetic modifica...
    SEP 02, 2020 7:00 AM PDT
    C.E. CREDITS
    SEP 02, 2020 7:00 AM PDT
    DATE: September 2, 2020 TIME: 03:00pm PDT, 6:00pm EDT Spatial omics is an expanding collection of methods to examine biological molecules in their geographical context. By retaining the prec...
    NOV 16, 2020 8:00 AM PST
    C.E. CREDITS
    NOV 16, 2020 8:00 AM PST
    Date: November 16, 2020 Time: 8:00am (PST), 11:00am (EST) CRISPR screening has become the prime discovery tool in modern biomedical research and drug discovery. At the same time, most screen...
    SEP 16, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 16, 2020 9:00 AM PDT
    Date: September 16, 2020 Time: 9:00am PTD, 12:00pm EDT Harnessing the power of the host immune system to treat diseases has been transformational in patient care. Physiologically relevant ce...
    Loading Comments...
    Show Resources
    Attendees
    • See more